Latest Insider Transactions at Gilead Sciences, Inc. (GILD)
This section provides a real-time view of insider transactions for Gilead Sciences, Inc. (GILD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of GILEAD SCIENCES, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of GILEAD SCIENCES, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 30
2025
|
Daniel Patrick O'Day Chairman & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-0.8%
|
$1,100,000
$110.54 P/Share
|
|
May 22
2025
|
Johanna Mercier Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
28,000
-6.9%
|
$2,996,000
$107.52 P/Share
|
|
May 22
2025
|
Johanna Mercier Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+8.38%
|
$1,650,000
$66.64 P/Share
|
|
May 15
2025
|
Andrew D Dickinson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-1.49%
|
$247,500
$99.82 P/Share
|
|
May 07
2025
|
Sandra Horning Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,516
+22.75%
|
-
|
|
May 07
2025
|
Harish Manwani Director |
SELL
Payment of exercise price or tax liability
|
Direct |
296
-2.06%
|
$29,008
$98.9 P/Share
|
|
May 07
2025
|
Harish Manwani Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,516
+9.53%
|
-
|
|
May 07
2025
|
Javier Rodriguez Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,516
+11.04%
|
-
|
|
May 07
2025
|
Anthony Welters Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,516
+11.43%
|
-
|
|
May 07
2025
|
Jacqueline K Barton Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,516
+5.5%
|
-
|
|
May 07
2025
|
Ted W Love Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,516
+25.9%
|
-
|
|
Apr 25
2025
|
Deborah H Telman EVP, Corporate Affairs & GC |
SELL
Payment of exercise price or tax liability
|
Direct |
158
-0.43%
|
$16,274
$103.17 P/Share
|
|
Apr 25
2025
|
Deborah H Telman EVP, Corporate Affairs & GC |
BUY
Exercise of conversion of derivative security
|
Direct |
514
+1.37%
|
-
|
|
Apr 15
2025
|
Andrew D Dickinson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-1.46%
|
$265,000
$106.4 P/Share
|
|
Mar 17
2025
|
Andrew D Dickinson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-1.44%
|
$275,000
$110.53 P/Share
|
|
Mar 10
2025
|
Johanna Mercier Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,907
-3.05%
|
$457,119
$117.21 P/Share
|
|
Mar 10
2025
|
Johanna Mercier Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,080
+5.94%
|
-
|
|
Mar 10
2025
|
Daniel Patrick O'Day Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,632
-1.81%
|
$1,360,944
$117.21 P/Share
|
|
Mar 10
2025
|
Daniel Patrick O'Day Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,024
+3.61%
|
-
|
|
Mar 10
2025
|
Deborah H Telman EVP, Corporate Affairs & GC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,130
-3.0%
|
$132,210
$117.21 P/Share
|
|
Mar 10
2025
|
Deborah H Telman EVP, Corporate Affairs & GC |
BUY
Exercise of conversion of derivative security
|
Direct |
3,343
+8.15%
|
-
|
|
Mar 10
2025
|
Andrew D Dickinson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,855
-2.18%
|
$451,035
$117.21 P/Share
|
|
Mar 10
2025
|
Andrew D Dickinson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,897
+4.52%
|
$1,631,511
$63.91 P/Share
|
|
Mar 10
2025
|
Andrew D Dickinson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
17,929
-4.89%
|
$2,097,693
$117.9 P/Share
|
|
Mar 10
2025
|
Sandra Patterson SVP, Controllership |
SELL
Payment of exercise price or tax liability
|
Direct |
624
-1.56%
|
$73,008
$117.21 P/Share
|
|
Mar 10
2025
|
Sandra Patterson SVP, Controllership |
BUY
Exercise of conversion of derivative security
|
Direct |
1,952
+4.64%
|
-
|
|
Feb 18
2025
|
Andrew D Dickinson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-1.46%
|
$260,000
$104.09 P/Share
|
|
Feb 12
2025
|
Andrew D Dickinson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
137,676
-44.57%
|
$14,042,952
$102.22 P/Share
|
|
Feb 12
2025
|
Andrew D Dickinson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
137,676
+10.78%
|
$9,774,996
$71.51 P/Share
|
|
Feb 04
2025
|
Sandra Patterson SVP, Controllership |
BUY
Grant, award, or other acquisition
|
Direct |
709
+1.84%
|
-
|
|
Feb 04
2025
|
Deborah H Telman EVP, Corporate Affairs & GC |
BUY
Grant, award, or other acquisition
|
Direct |
12,371
+26.67%
|
-
|
|
Feb 04
2025
|
Daniel Patrick O'Day Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
108,156
-14.9%
|
$10,491,132
$97.99 P/Share
|
|
Feb 04
2025
|
Daniel Patrick O'Day Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
224,504
+14.06%
|
-
|
|
Feb 04
2025
|
Andrew D Dickinson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
43,138
-20.12%
|
$4,184,386
$97.99 P/Share
|
|
Feb 04
2025
|
Andrew D Dickinson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
84,488
+17.43%
|
-
|
|
Feb 04
2025
|
Johanna Mercier Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
45,666
-27.57%
|
$4,429,602
$97.99 P/Share
|
|
Feb 04
2025
|
Johanna Mercier Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
90,505
+23.58%
|
-
|
|
Jan 31
2025
|
Andrew D Dickinson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
142,180
-52.26%
|
$13,791,460
$97.22 P/Share
|
|
Jan 31
2025
|
Andrew D Dickinson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
142,180
+17.42%
|
$9,241,700
$65.21 P/Share
|
|
Jan 25
2025
|
Deborah H Telman EVP, Corporate Affairs & GC |
SELL
Payment of exercise price or tax liability
|
Direct |
187
-0.86%
|
$17,391
$93.07 P/Share
|
|
Jan 25
2025
|
Deborah H Telman EVP, Corporate Affairs & GC |
BUY
Exercise of conversion of derivative security
|
Direct |
515
+2.31%
|
-
|
|
Jan 15
2025
|
Andrew D Dickinson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-1.89%
|
$227,500
$91.35 P/Share
|
|
Dec 16
2024
|
Andrew D Dickinson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,500
-6.03%
|
$773,500
$91.96 P/Share
|
|
Dec 13
2024
|
Sandra Patterson SVP, Controllership |
SELL
Payment of exercise price or tax liability
|
Direct |
157
-0.42%
|
$14,287
$91.86 P/Share
|
|
Dec 13
2024
|
Sandra Patterson SVP, Controllership |
BUY
Exercise of conversion of derivative security
|
Direct |
157
+0.42%
|
-
|
|
Dec 10
2024
|
Deborah H Telman EVP, Corporate Affairs & GC |
SELL
Payment of exercise price or tax liability
|
Direct |
306
-1.42%
|
$28,152
$92.34 P/Share
|
|
Dec 10
2024
|
Deborah H Telman EVP, Corporate Affairs & GC |
BUY
Exercise of conversion of derivative security
|
Direct |
639
+2.87%
|
-
|
|
Dec 10
2024
|
Sandra Patterson SVP, Controllership |
SELL
Payment of exercise price or tax liability
|
Direct |
408
-1.09%
|
$37,536
$92.34 P/Share
|
|
Dec 10
2024
|
Sandra Patterson SVP, Controllership |
BUY
Exercise of conversion of derivative security
|
Direct |
901
+2.35%
|
-
|
|
Dec 10
2024
|
Merdad Parsey Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,771
-2.09%
|
$162,932
$92.34 P/Share
|